puromycin aminonucleoside has been researched along with epidermal growth factor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fraser, S; Kanellis, J; Katerelos, M; Khong, T; Kirkland, G; Paizis, K; Power, DA | 1 |
Fraser, S; Hill, PA; Katerelos, M; Khong, TF; Paizis, K; Power, DA | 1 |
2 other study(ies) available for puromycin aminonucleoside and epidermal growth factor
Article | Year |
---|---|
Heparin-binding epidermal growth factor-like growth factor is expressed in the adhesive lesions of experimental focal glomerular sclerosis.
Topics: Actins; Animals; Creatinine; Disease Models, Animal; Epidermal Growth Factor; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Heparin-binding EGF-like Growth Factor; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Macrophages; Male; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Up-Regulation | 1999 |
Inhibition of heparin-binding epidermal growth factor-like growth factor increases albuminuria in puromycin aminonucleoside nephrosis.
Topics: 3T3 Cells; Actins; Albuminuria; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibody Specificity; Cell Adhesion; CHO Cells; COS Cells; Cricetinae; Epidermal Growth Factor; Female; Flow Cytometry; Glomerular Filtration Rate; Heparin-binding EGF-like Growth Factor; Humans; Integrin alpha3beta1; Integrins; Intercellular Signaling Peptides and Proteins; Kidney; Mice; Mice, Inbred BALB C; Microscopy, Confocal; Microscopy, Electron; Nephrosis; Neutralization Tests; Puromycin Aminonucleoside; Rats; Transfection | 2000 |